272.F

Healthcare Biotechnology

Mabion S.A.

€1.75

+0.05 +3.06% today

Price History

Not enough data

Key Stats

Market Cap

28.35M

Avg Volume

EPS

-€0.83

52W High

€2.20

52W Low

€1.58

Div. Yield

0.0%

Valuation

P/B Ratio

0.40

Margins

Gross Margin (50.6%)

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin (167.9%)

Growth & Returns

Revenue Growth (YoY)

0.1%

Return on Equity

(107.9%)

Return on Assets

(20.7%)

Liquidity & Leverage

Current Ratio

0.32

Quick Ratio

0.16

Debt / Equity

1.34

About

Mabion S.A., a biopharmaceutical company, provides contract development, analytics, and manufacturing services for biologics in Poland. It offers drug substance manufacturing, process development, analytics, and cell line development services. The company also provides medicines for cancer, autoimmune diseases, rare diseases, and other diseases. The company was founded in 2007 and is headquartered in Konstantynów Lódzki, Poland.